Tadalafil
Who holds supplier records for Tadalafil? 32 organisations hold a current record for Tadalafil: an active US FDA Type II Drug Master File or a CEP. A further 2 organisations have only historical (inactive) DMF filings. 24 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: India (18), China (6), Netherlands (1), Poland (1) and 1 other country (1); not recorded for 5.
Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records
Cite as: PharmaTek, “Tadalafil: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/tadalafil
Reading the evidence
- 32 current records
Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.
- Most recorded organisations are in India
18 of the 27 current records with a recorded country list India. Organisation country is not necessarily the manufacturing site.
- 14 with a company-level GMP certificate on record
These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.
- US product patents listed
The latest patent listed in the FDA Orange Book for an approved product containing Tadalafil expires 24 Dec 2038. Product, formulation and method-of-use patents do not by themselves stop the ingredient being supplied or other products being approved.
Current records (32)
Organisations holding an active US FDA Type II Drug Master File or a CEP for Tadalafil. Country is the organisation's recorded country, not necessarily the manufacturing site.
- ALIVUS LIFE SCIENCES LTDIndiaCEP Company GMP cert on recordActive DMF 22530, 29595 · latest filing Sept 2015
- MSN Organics Private LimitedIndiaCEPActive DMF 26786, 25513 · latest filing Feb 2013
- Alembic Pharmaceuticals LimitedIndiaCEP Company GMP cert on recordActive DMF 22707 · latest filing Mar 2009
- AMI LIFESCIENCES PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 37995 · latest filing Feb 2023
- APITORIA PHARMA PRIVATE LTDIndiaCEP Company GMP cert on recordActive DMF 25694 · latest filing Jan 2012
- HONOUR LAB LTDIndiaCEP Company GMP cert on recordActive DMF 29765 · latest filing Dec 2015
- JUBILANT BIOSYS LTDIndiaCEPActive DMF 27246 · latest filing Jun 2013
- Macleods Pharmaceuticals Ltd.IndiaCEP Company GMP cert on recordActive DMF 26139 · latest filing Apr 2013
- MATRIX PHARMACORP PRIVATE LTDIndiaCEPActive DMF 20640 · latest filing Jun 2007
- RUYUAN HEC PHARM CO LTDCEPActive DMF 32453 · latest filing Jan 2018
- Shandong Anxin Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 30860 · latest filing Sept 2016
- SMS Pharmaceuticals limitedIndiaCEP Company GMP cert on recordActive DMF 24206 · latest filing Sept 2010
- TAPI NL BVNetherlandsCEPActive DMF 20884 · latest filing Sept 2007
- TOPHARMAN SHANDONG CO LTDChinaCEPActive DMF 33012 · latest filing Aug 2018
- Unichem Laboratories Ltd.IndiaCEP Company GMP cert on recordActive DMF 29027 · latest filing Feb 2015
- Zakłady Farmaceutyczne Polpharma S.A.PolandCEP Company GMP cert on recordActive DMF 24590 · latest filing Jan 2011
- Zhejiang Huahai Pharmaceutical Co., Ltd.ChinaCEP Company GMP cert on recordActive DMF 27479 · latest filing Sept 2013
- AMOLI ORGANICS (A DIVISION OF UMEDICA LABORATORIES PVT LTD)IndiaActive DMF 30608 · latest filing Jun 2016
- Apotex Pharmachem India Pvt. Ltd.IndiaActive DMF 25815 · latest filing Feb 2012
- AZICO BIOPHORE INDIA PVT LTDIndiaActive DMF 37751 · latest filing Jan 2023
- Orchid Pharma LimitedIndia Company GMP cert on recordActive DMF 20962 · latest filing Oct 2007
- SHANDONG LUNING PHARMACEUTICAL CO LTDActive DMF 39503 · latest filing Feb 2024
- Shandong New Time Pharmaceutical Co LtdCompany GMP cert on recordActive DMF 37915 · latest filing Jan 2023
- Sun Pharmaceutical Industries LimitedIndia Company GMP cert on recordActive DMF 29316, 22771 · latest filing Jun 2015
- Zhejiang Yongning Pharmaceutical Co., LtdChinaActive DMF 33502 · latest filing Apr 2019
- IndiaCEP
- RAKSHIT PHARMACEUTICALS LTDCEP
- ChinaCEP
- SHANDONG HAIYOU FREDA PHARMACEUTICAL CO LTDCEP
- ANHUI BIOCHEM PHARMACEUTICAL CO., LTD.ChinaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- ASSURGEN PHARMA PRIVATE LIMITEDIndiaCEPValid CEP holder (EDQM); not necessarily the manufacturer
- Interquim, S.A.SpainCEPValid CEP holder (EDQM); not necessarily the manufacturer
The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.
Valid CEP holder entries (24)
Certificates of Suitability on the EDQM register for Tadalafil, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 28 certificates in total, including withdrawn, expired, suspended and repeat certificates.
| Holder | Country | Certificate | Issued | EU GMP at holder's address |
|---|---|---|---|---|
| ALIVUS LIFE SCIENCES LIMITED Mumbai | IN | CEP 2016-040 - Rev 02 Tadalafil, D150 process | May 2026 | — |
| ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. Fuyang | CN | CEP 2024-224 - Rev 00 Tadalafil | Apr 2026 | — |
| ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam | IN | CEP 2021-498 - Rev 01 Tadalafil | Apr 2026 | Inspected May 2023 Hungary, outside 3-year window |
| AMOLI ORGANICS PRIVATE LIMITED Mumbai | IN | CEP 2016-183 - Rev 02 Tadalafil | Apr 2026 | — |
| SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou | CN | CEP 2025-131 - Rev 01 Tadalafil | Feb 2026 | — |
| JUBILANT BIOSYS LIMITED Mysuru | IN | CEP 2013-276 - Rev 02 Tadalafil | Jan 2026 | — |
| MSN ORGANICS PRIVATE LIMITED Bibinagar Village | IN | CEP 2011-366 - Rev 01 Tadalafil, Form-I, Micronised, Non-micronised, Milled and Non-milled | Dec 2025 | — |
| MATRIX PHARMACORP PRIVATE LIMITED Sangareddy District | IN | CEP 2019-201 - Rev 04 Tadalafil, Process II | Sept 2025 | — |
| UNICHEM LABORATORIES LIMITED Mumbai | IN | CEP 2015-132 - Rev 01 Tadalafil | Jul 2025 | — |
| RAKSHIT PHARMACEUTICALS LIMITED Anakapalli District | IN | CEP 2016-317 - Rev 01 Tadalafil | May 2025 | — |
| TAPI NL B.V. Amsterdam | NL | CEP 2013-152 - Rev 03 Tadalafil | Mar 2025 | — |
| ALEMBIC PHARMACEUTICALS LIMITED Vadodara | IN | CEP 2011-316 - Rev 01 Tadalafil | Feb 2025 | — |
| RUYUAN HEC PHARM CO., LTD. Shaoguan | CN | CEP 2018-005 - Rev 01 Tadalafil | Oct 2024 | — |
| SMS PHARMACEUTICALS LIMITED Hyderabad | IN | CEP 2014-308 - Rev 01 Tadalafil | Sept 2024 | — |
| TOPHARMAN SHANDONG CO., LTD. Weifang | CN | CEP 2018-179 - Rev 02 Tadalafil, Unmilled; milled | Jul 2024 | — |
| AMI LIFESCIENCES PRIVATE LIMITED Karakhadi | IN | CEP 2014-339 - Rev 03 Tadalafil | Feb 2024 | Inspected Oct 2025 Slovakia |
| APITORIA PHARMA PRIVATE LIMITED Hyderabad | IN | CEP 2012-232 - Rev 01 Tadalafil | Nov 2023 | — |
| ZAKŁADY FARMACEUTYCZNE POLPHARMA S.A. Starogard Gdański | PL | CEP 2012-150 - Rev 02 Tadalafil | Oct 2023 | Inspected Jul 2026 Poland |
| SHANDONG HAIYOU FREDA PHARMACEUTICAL CO. LTD. Linyi | CN | R0-CEP 2021-487 - Rev 00 Tadalafil | May 2023 | — |
| MACLEODS PHARMACEUTICALS LIMITED Mumbai | IN | R1-CEP 2016-190 - Rev 00 Tadalafil | Feb 2023 | — |
| HONOUR LAB LIMITED Hyderabad | IN | R1-CEP 2016-083 - Rev 00 Tadalafil | Jul 2022 | — |
| ZHEJIANG HUAHAI PHARMACEUTICAL CO., LTD. Linhai | CN | R1-CEP 2013-189 - Rev 02 Tadalafil | Feb 2022 | — |
| SHANDONG ANXIN PHARMACEUTICAL CO., LTD. Dongjia Town | CN | R1-CEP 2016-001 - Rev 00 Tadalafil | Feb 2022 | — |
| Interquim, S.A. Sant Cugat Del Vallès | ES | R1-CEP 2015-101 - Rev 00 Tadalafil | Apr 2021 | — |
The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.
Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.
Historical records (2)
Organisations whose Type II DMFs for Tadalafil are no longer active. These show a past filing, not current supply.
Show all 2 historical records
- AMI LIFE SCIENCES PRIVATE LTDInactive DMF 25355 · filed Oct 2011
- India · Inactive DMF 21209 · filed Jan 2008
US product patents and exclusivity
The FDA Orange Book lists patents and exclusivities for specific approved products (122 listed products contain Tadalafil). The latest listed patent expires 24 Dec 2038. These dates are product-specific: they can cover a formulation, a combination or a method of use, and do not on their own show whether the ingredient is protected or whether generics are already approved. Check the individual product entries before planning a launch.
Overview
Tadalafil is a phosphodiesterase type 5 (PDE5) inhibitor used to treat erectile dysfunction, benign prostatic hyperplasia, and pulmonary arterial hypertension. It helps in relaxing muscles of the blood vessels, increasing blood flow to specific areas of the body.
Chemical identity
- IUPAC name
- (2R,8R)-2-(1,3-benzodioxol-5-yl)-6-methyl-3,6,17-triazatetracyclo[8.7.0.03,8.011,16]heptadeca-1(10),11,13,15-tetraene-4,7-dione
- Canonical SMILES
- CN1CC(=O)N2[C@@H](C1=O)CC3=C([C@H]2C4=CC5=C(C=C4)OCO5)NC6=CC=CC=C36
- InChIKey
- WOXKDUGGOYFFRN-MRVPVSSYSA-N
- Synonyms
- Adcirca API
Pharmacologic class
As the US FDA states it for this active substance on product listings.
- Established pharmacologic class
- Phosphodiesterase 5 Inhibitor
- Mechanism of action
- Phosphodiesterase 5 Inhibitors
Therapeutic areas
Record history
No change to the current records between 13 Nov 2026 and 16 Nov 2026.
Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week
What these records establish
- An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
- A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
- Historical records show a past filing, not current supply.
- Company GMP certificates are matched to the organisation, not to the site making this substance.
- A substance missing from these registers is not evidence that no supplier exists.
Frequently asked questions
Which organisations hold current supplier records for Tadalafil?
32 organisations hold an active US FDA Type II Drug Master File or a CEP for Tadalafil: ALIVUS LIFE SCIENCES LTD (India), MSN Organics Private Limited (India), Alembic Pharmaceuticals Limited (India), AMI LIFESCIENCES PRIVATE LTD (India), APITORIA PHARMA PRIVATE LTD (India), HONOUR LAB LTD (India), JUBILANT BIOSYS LTD (India) and Macleods Pharmaceuticals Ltd. (India), and 24 more listed on this page. A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.
Which Tadalafil Drug Master Files are active?
ALIVUS LIFE SCIENCES LTD (DMF 22530, 29595), MSN Organics Private Limited (DMF 26786, 25513), Alembic Pharmaceuticals Limited (DMF 22707), AMI LIFESCIENCES PRIVATE LTD (DMF 37995), APITORIA PHARMA PRIVATE LTD (DMF 25694), HONOUR LAB LTD (DMF 29765), JUBILANT BIOSYS LTD (DMF 27246) and Macleods Pharmaceuticals Ltd. (DMF 26139) and 17 more. The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.
What do the historical Tadalafil records mean?
2 organisations have only inactive Type II DMFs for Tadalafil. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.
Does Tadalafil have a European Certificate of Suitability?
Yes. 24 organisations hold a valid CEP for Tadalafil on the EDQM register, including ALIVUS LIFE SCIENCES LIMITED Mumbai (IN), ANHUI BIOCHEM PHARMACEUTICAL CO., LTD. Fuyang (CN), ASSURGEN PHARMA PRIVATE LIMITED Visakhapatnam (IN), AMOLI ORGANICS PRIVATE LIMITED Mumbai (IN), SHANDONG CHENGHUI SHUANGDA PHARMACEUTICAL CO., LTD. Dezhou (CN) and JUBILANT BIOSYS LIMITED Mysuru (IN) and 18 more. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.
Does the FDA Orange Book list patents for products containing Tadalafil?
Yes. The latest patent listed for an approved US product containing Tadalafil expires 24 Dec 2038, across 122 listed products. These patents protect specific products, formulations or uses. They do not by themselves mean the ingredient is protected, and generic versions of other products may already be approved.
How do I qualify a Tadalafil supplier?
Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.
Do you supply Tadalafil?
Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.